James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 5,050 shares at $77.19 ($391K) on 2019-02-07, disclosed to the SEC on 2019-02-11.
Seasonal sale ($391k) by Chief Commercial Officer — this insider has traded GHDX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.19 | 2,050 | $158K | 40.5% |
| 2 | $77.19 | 2,050 | $158K | 40.5% |
| 3 | $77.94 | 950 | $74K | 19.0% |
| Total | $77.33 avg | 5,050 | $391K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |